Gritstone bio, Inc. (NASDAQ: GRTS) reported Q3 EPS of ($0.33), $0.01 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.57 million versus the consensus estimate of $1.89 million.

For earnings history and earnings-related data on Gritstone bio, Inc. (GRTS) click here.